Three-Dimensional Breast Cancer Model to Investigate CCL5/CCR1 Expression Mediated by Direct Contact between Breast Cancer Cells and Adipose-Derived Stromal Cells or Adipocytes.

3D breast cancer model adipocytes adipose tissue adipose-derived stromal cells co-culture spheroids

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
05 Jul 2023
Historique:
received: 17 05 2023
revised: 26 06 2023
accepted: 28 06 2023
medline: 14 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

The tumor microenvironment (TME) in breast cancer is determined by the complex crosstalk of cancer cells with adipose tissue-inherent cells such as adipose-derived stromal cells (ASCs) and adipocytes resulting from the local invasion of tumor cells in the mammary fat pad. This leads to heterotypic cellular contacts between these cell types. To adequately mimic the specific cell-to-cell interaction in an in vivo-like 3D environment, we developed a direct co-culture spheroid model using ASCs or differentiated adipocytes in combination with MDA-MB-231 or MCF-7 breast carcinoma cells. Co-spheroids were generated in a well-defined and reproducible manner in a high-throughput process. We compared the expression of the tumor-promoting chemokine CCL5 and its cognate receptors in these co-spheroids to indirect and direct standard 2D co-cultures. A marked up-regulation of CCL5 and in particular the receptor CCR1 with strict dependence on cell-cell contacts and culture dimensionality was evident. Furthermore, the impact of direct contacts between ASCs and tumor cells and the involvement of CCR1 in promoting tumor cell migration were demonstrated. Overall, these results show the importance of direct 3D co-culture models to better represent the complex tumor-stroma interaction in a tissue-like context. The unveiling of tumor-specific markers that are up-regulated upon direct cell-cell contact with neighboring stromal cells, as demonstrated in the 3D co-culture spheroids, may represent a promising strategy to find new targets for the diagnosis and treatment of invasive breast cancer.

Identifiants

pubmed: 37444610
pii: cancers15133501
doi: 10.3390/cancers15133501
pmc: PMC10341373
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Bavarian Research Foundation
ID : AZ-1365-18
Organisme : German Research Foundation
ID : 326998133, TRR 225

Références

Cancer Res. 2016 Jan 15;76(2):491-504
pubmed: 26744520
Front Pharmacol. 2021 Feb 26;11:632079
pubmed: 33716731
Ann Plast Surg. 2018 Apr;80(4 Suppl 4):S223-S228
pubmed: 29481479
Cancer Sci. 2009 Dec;100(12):2309-17
pubmed: 19735487
Blood. 2001 Feb 15;97(4):1144-6
pubmed: 11159551
J Steroid Biochem Mol Biol. 2012 Sep;131(3-5):68-75
pubmed: 22265957
Int J Dev Biol. 2011;55(7-9):851-9
pubmed: 21948738
Mol Oncol. 2007 Jun;1(1):84-96
pubmed: 18516279
Cancer Lett. 2009 Oct 18;284(1):80-5
pubmed: 19427114
Front Physiol. 2021 Nov 29;12:751239
pubmed: 34912237
Int J Mol Sci. 2022 Nov 16;23(22):
pubmed: 36430633
Cancer Res. 1999 Sep 15;59(18):4681-7
pubmed: 10493525
Cell Death Dis. 2017 May 25;8(5):e2819
pubmed: 28542126
Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13063-8
pubmed: 20616008
Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4133-4144
pubmed: 35674738
Int J Mol Sci. 2018 Jan 18;19(1):
pubmed: 29346265
Nat Commun. 2019 Jul 5;10(1):2983
pubmed: 31278301
Adv Funct Mater. 2020 Nov 25;30(48):
pubmed: 33692663
Mini Rev Med Chem. 2015;15(13):1063-72
pubmed: 26420723
MedComm (2020). 2022 Jun 08;3(2):e147
pubmed: 35702353
Oncol Rep. 2019 Dec;42(6):2499-2511
pubmed: 31578575
Expert Opin Ther Targets. 2014 Nov;18(11):1265-75
pubmed: 25256399
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Trends Cancer. 2018 May;4(5):374-384
pubmed: 29709261
Oncotarget. 2017 May 20;8(34):57622-57641
pubmed: 28915700
Cell Adh Migr. 2013 May-Jun;7(3):315-24
pubmed: 23722213
J Hematol Oncol. 2019 Sep 10;12(1):95
pubmed: 31500658
Nat Rev Cancer. 2004 Jul;4(7):540-50
pubmed: 15229479
Nature. 2007 Oct 4;449(7162):557-63
pubmed: 17914389
Carcinogenesis. 2011 Apr;32(4):477-87
pubmed: 21252118
Bioeng Transl Med. 2021 Dec 31;7(2):e10286
pubmed: 35600659
Cytokine. 2013 Oct;64(1):251-7
pubmed: 23876400
Oncotarget. 2016 Apr 26;7(17):24495-509
pubmed: 27027351
Adv Sci (Weinh). 2021 Jun;8(11):e2004856
pubmed: 34105271
Oncotarget. 2017 Oct 10;8(55):94591-94605
pubmed: 29212252
Compr Physiol. 2017 Dec 12;8(1):237-282
pubmed: 29357128
Cancer Res. 2011 Apr 1;71(7):2455-65
pubmed: 21459803
Int J Cancer. 2008 Feb 15;122(4):769-76
pubmed: 17935139
Clin Cancer Res. 2001 Feb;7(2):285-9
pubmed: 11234881
Cells. 2021 Apr 03;10(4):
pubmed: 33916870
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Cells. 2019 Aug 08;8(8):
pubmed: 31398937
Breast Cancer Res. 2005;7(3):R274-83
pubmed: 15987422
Cancers (Basel). 2022 Aug 12;14(16):
pubmed: 36010901
Tissue Eng Part A. 2018 Sep;24(17-18):1309-1319
pubmed: 29652604
J Mammary Gland Biol Neoplasia. 2019 Mar;24(1):85-97
pubmed: 30474817
Front Immunol. 2020 Jun 04;11:952
pubmed: 32582148
Front Physiol. 2017 Aug 22;8:605
pubmed: 28878686
Tissue Eng Regen Med. 2020 Dec;17(6):773-785
pubmed: 32939672
Int J Mol Med. 2006 May;17(5):849-56
pubmed: 16596270
Front Immunol. 2019 Apr 12;10:757
pubmed: 31031757
Am J Clin Pathol. 2008 Sep;130(3):382-8
pubmed: 18701411
J Tissue Eng Regen Med. 2015 Mar;9(3):310-4
pubmed: 23307775
Cancer Sci. 2018 Mar;109(3):710-723
pubmed: 29285854
J Clin Med. 2020 Apr 02;9(4):
pubmed: 32252260
Int J Mol Sci. 2021 Feb 15;22(4):
pubmed: 33671956
Cancers (Basel). 2019 Aug 24;11(9):
pubmed: 31450577
J Nucl Med. 2019 Jan;60(1):60-64
pubmed: 29777009

Auteurs

Martin Watzling (M)

Department of Trauma, Hand, Plastic and Reconstructive Surgery, University Hospital Würzburg, 97080 Würzburg, Germany.

Lorenz Klaus (L)

Department of Trauma, Hand, Plastic and Reconstructive Surgery, University Hospital Würzburg, 97080 Würzburg, Germany.

Tamara Weidemeier (T)

Department of Trauma, Hand, Plastic and Reconstructive Surgery, University Hospital Würzburg, 97080 Würzburg, Germany.

Hannes Horder (H)

Department of Trauma, Hand, Plastic and Reconstructive Surgery, University Hospital Würzburg, 97080 Würzburg, Germany.

Regina Ebert (R)

Department of Musculoskeletal Tissue Regeneration, Julius-Maximilians-Universität Würzburg, 97074 Würzburg, Germany.

Torsten Blunk (T)

Department of Trauma, Hand, Plastic and Reconstructive Surgery, University Hospital Würzburg, 97080 Würzburg, Germany.

Petra Bauer-Kreisel (P)

Department of Trauma, Hand, Plastic and Reconstructive Surgery, University Hospital Würzburg, 97080 Würzburg, Germany.

Classifications MeSH